VENLO, THE NETHERLANDS -- (MARKET WIRE) -- November 06, 2006 -- QIAGEN, the worldwide leading provider of products for pre-analytical sample preparation and a leader in molecular diagnostics, today introduced its new Biomedical Tissue Management System. At a press briefing held in Düsseldorf at the BIO Europe 2006 conference, QIAGEN’s CEO Peer Schatz, presented this comprehensive set of integrated solutions which standardize the entire workflow for the processing of tissues samples, from the sample collection to data analysis. The Biomedical Tissue Management System includes a wide array of QIAGEN products including stabilization solutions to prevent degradation of DNA and RNA, instruments for the release of bio-molecules from tissue samples and technologies for reproducible purification and Polymerase Chain Reaction (PCR), the standard process for making target molecular sequences visible.
